MARIZYME, INC.
MARIZYME, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | |||||
Accounts Receivable Net Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | |||||
Accounts And Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Noncurrent | |||||||||||||||||
Assets Noncurrent | 20 | 21 | 21 | 21 | 36 | 36 | 36 | 37 | 61 | 62 | 61 | 62 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | |||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 27 | 28 | 52 | 52 | 53 | 53 | |||||
Deposits Assets Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | |||||
Finite Lived Intangible Assets Net | 14 | 14 | 14 | 14 | 27 | 27 | - | 28 | - | - | - | - | |||||
Prepaid Expense Other Noncurrent | - | - | - | 0 | 0 | - | - | 0 | - | - | - | - | |||||
Prepaid Expense Noncurrent | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Deposit Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Goodwill | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Assets | 21 | 22 | 22 | 22 | 37 | 37 | 38 | 39 | 64 | 64 | 65 | 66 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | |||||
Notes Payable Current | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 30 | 24 | 26 | 23 | 49 | 21 | 8 | 3 | 2 | 2 | 2 | 3 | |||||
Due To Related Parties Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 1 | |||||
Other Liabilities Current | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Convertible Debt Current | 17 | 17 | 16 | 16 | 19 | 12 | 4 | - | - | - | - | - | |||||
Derivative Liabilities Current | - | - | - | - | 26 | 5 | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | 7 | 7 | 7 | 6 | 10 | 9 | 15 | 18 | 21 | 21 | 18 | 15 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Derivative Liabilities Noncurrent | - | - | - | - | - | - | 5 | 5 | 5 | 4 | 4 | 2 | |||||
Convertible Debt Noncurrent | - | - | - | - | 0 | 0 | - | 3 | 2 | 1 | 0 | - | |||||
Contingent Consideration Classified As Equity Fair… | 5 | 6 | 6 | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 37 | 31 | 32 | 29 | 59 | 30 | 23 | 21 | 23 | 23 | 20 | 18 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 155 | 152 | 147 | 149 | 120 | 116 | 104 | 103 | 103 | 102 | 99 | 95 | |||||
Retained Earnings Accumulated Deficit | -170 | -162 | -158 | -156 | -142 | -109 | -89 | -86 | -62 | -61 | -54 | -48 | |||||
Stockholders Equity | -16 | -9 | -11 | -7 | -29 | 7 | 15 | 17 | 41 | 41 | 45 | 48 | |||||
Liabilities And Stockholders Equity | 21 | 22 | 22 | 22 | 37 | 37 | 38 | 39 | 64 | 64 | 65 | 66 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 300 | 300 | 2,000 | 75 | 75 | 75 | 75 | |||||
Common Stock Shares Issued | 132 | 132 | 132 | 132 | 47 | 45 | 41 | 41 | 41 | 41 | 41 | 41 | |||||
Shares Outstanding | 132 | 132 | 132 | 132 | 47 | 45 | 41 | 41 | 41 | 41 | 41 | 41 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -41.83% | -46.24% | -65.59% | 34.06% | 56.09% | 9.37% | -83.80% | -99.40% | -99.40% | - | - | - |
| 2023 | 44.65% | -59.18% | -18.37% | 51.68% | 178.08% | 55.89% | -14.21% | -10.68% | -28.57% | 69.09% | -1.64% | -40.00% |
| 2022 | 9.52% | 31.43% | 7.14% | 4.55% | -13.64% | -13.64% | -52.11% | -60.53% | -73.68% | -49.99% | -73.74% | -55.69% |
| 2021 | - | - | - | - | - | - | - | - | - | -1.55% | 5.67% | 28.87% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | 0.05 | 0.23 | 0.67 | 1.46 | 1.74 | 2.23 | 1.40 | |||||
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.06 | 0.21 | 0.78 | 1.41 | 1.93 | 1.32 | |||||
| Working Capital | -29.12M | -22.63M | -25.11M | -21.67M | -47.35M | -19.76M | -6.15M | -966.46K | 735.53K | 1.11M | 2.03M | 1.27M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -2.37 | -3.30 | -2.99 | -4.29 | -2.00 | 4.09 | 1.51 | 1.22 | 0.56 | 0.56 | 0.44 | 0.38 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | - | - | -2,388.68 | -2,105.84 | |||||
| Debt Ratio | 1.73 | 1.44 | 1.50 | 1.30 | 1.59 | 0.80 | 0.60 | 0.55 | 0.36 | 0.36 | 0.30 | 0.28 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 16.60 | - | - | 41.85 | 44.37 | 55.01 | 43.71 | 75.39 | 146.68 | 635.52 | 59.48 | 42.73 | |||||
| Receivables Turnover TTM | 21.99 | - | - | 8.72 | 8.23 | 6.64 | 8.35 | 4.84 | 2.49 | 0.57 | 6.14 | 8.54 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.24 | -0.43 | -0.56 | -1.53 | -1.60 | -1.12 | -0.85 | -0.94 | -0.46 | -0.46 | - | - | |||||
| Free Cash Flow Per Share TTM | -0.03 | -0.03 | -0.03 | -0.10 | -0.11 | -0.14 | -0.19 | -0.27 | -0.26 | -0.24 | -0.20 | -0.16 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | 71.17% | 70.87% | 105.60% | 84.45% | 74.18% | - | - | - | - | - | |||||
| Operating Profit Margin TTM | -5,352.51% | -6,096.28% | -6,062.63% | -5,278.10% | -9,552.42% | -8,527.38% | -9,783.54% | -15,985.52% | -6,743.60% | -24,551.01% | -7,339.83% | -4,195.09% | |||||
| Net Profit Margin TTM | -6,461.17% | -11,480.91% | -13,318.58% | -10,767.77% | -18,273.19% | -11,536.40% | -9,544.68% | -16,346.18% | -9,983.63% | -37,934.71% | -10,498.48% | -5,230.16% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 24.03% | 18.10% | 51.66% | 176.60% | 114.04% | 745.00% | 165.87% | 11.04% | 71.23% | -86.17% | -49.71% | 6.67% | |||||
| Net Income Growth (1Y) | -56.14% | 17.53% | 111.62% | 82.20% | 291.75% | 156.97% | 141.72% | 247.03% | 91.22% | 83.89% | 74.88% | 88.16% | |||||
| EPS Growth (1Y) | -84.76% | -61.49% | -34.56% | 63.19% | 249.13% | 142.94% | 140.95% | 207.10% | 68.27% | 61.82% | 54.65% | 87.57% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.20 | -0.13 | -0.16 | -0.07 | -0.14 | -0.07 | -0.33 | -0.57 | -4.15 | -5.85 | -5.51 | -5.80 | |||||
| P/B TTM | -0.42 | -0.76 | -1.08 | -0.68 | -0.34 | 0.48 | 0.75 | 1.24 | 1.89 | 2.66 | 1.74 | 1.34 | |||||
| P/S TTM | 13.24 | 14.44 | 21.20 | 7.05 | 25.15 | 8.26 | 31.60 | 92.45 | 414.24 | 2,219.01 | 578.16 | 303.38 | |||||
| Market Cap | 6.58M | 7.13M | 11.65M | 4.55M | 10.08M | 3.45M | 11.45M | 21.59M | 77.57M | 109.83M | 78.82M | 63.79M | |||||
| Enterprise Value | 25.96M | 25.69M | 28.76M | 21.37M | 29.01M | 16.16M | 16.76M | 24.96M | 78.25M | 108.87M | 76.25M | 60.32M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -3.74M | -3.91M | -4.37M | -4.68M | -5.06M | -6.11M | -7.66M | -10.85M | -10.74M | -9.87M | -8.04M | -5.79M | |||||
| Net Debt | 19.37M | 18.56M | 17.10M | 16.81M | 18.93M | 12.70M | 5.31M | 3.37M | 680.11K | -960.64K | -2.57M | -3.48M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
MARIZYME, INC. (MRZM) — SEC Financial Statements & Analysis
MARIZYME, INC. (MRZM) is a surgical & medical instruments & apparatus company, incorporated in NV. MARIZYME, INC. trades on OTC as: MRZM. Based on its latest SEC filing (Form 10-Q, period ending 2024-09-30), MARIZYME, INC. reported a 24.03% year-over-year revenue growth, a Gross Profit Margin of 71.17% (TTM), a Debt-to-Equity ratio of -2.37x, a Price-to-Sales (P/S) ratio of 13.24x (TTM), a Price-to-Book (P/B) ratio of -0.42x (TTM), at a market cap of $6.58M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 24.03%
- Gross Profit Margin TTM
- 71.17%
- Debt To Equity
- -2.37x
- P/S TTM
- 13.24x
- P/B TTM
- -0.42x
- Market Cap
- $6.58M
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MARIZYME, INC. in?
MARIZYME, INC. (MRZM) operates in the Surgical & Medical Instruments & Apparatus industry.
What is MRZM's market cap?
MARIZYME, INC. (MRZM) has a market capitalization of $6.58M as of 2024-09-30.
What exchange does MRZM trade on?
MARIZYME, INC. (MRZM) trades on the OTC.
Where is MARIZYME, INC. incorporated?
MARIZYME, INC. is incorporated in NV.